Evaluation of the Variation of the Intestinal Microbiota and the Integrity of the Intestinal Barrier in Patients With M.D.R. Germ-induced Pneumonia Undergoing Enteral Nutrition
NCT06485791 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2024-07-03
Summary
The study aims to evaluate the effects of enteral nutrition in subjects with MDR on the intestinal microbiota
Conditions
- Multi Drug Resistant
- Dysphagia
Sponsors & Collaborators
-
Russo Francesco, MD
collaborator UNKNOWN -
Rossella Donghia, Biologist
collaborator UNKNOWN -
Maria Notarnicola, Clinical Pathology Director
collaborator UNKNOWN -
Pasqua Letizia Pesole, Biologist
collaborator UNKNOWN -
Sergio Coletta, Laboratory Technician
collaborator UNKNOWN -
Anna Ancora, Laboratory Technician
collaborator UNKNOWN -
Francesco Gabriele, Intensive Care Unit Director
collaborator UNKNOWN -
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
lead OTHER
Principal Investigators
-
Nicola Cappellano, MD · Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-01
- Primary Completion
- 2025-07-01
- Completion
- 2026-07-01
More Related Trials
-
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
NCT04668014 ·Status: COMPLETED
-
Intestinal Microbiome and Chemotherapy
NCT02875249 ·Status: COMPLETED
-
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection
NCT03353506 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections
NCT01232595 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Colonic Carriage of Staphylococcus Aureus in a Prospective Cohort of Patients Undergoing Endoscopic Screening for Digestive Cancer in the University Hospital of Saint-Etienne
NCT02502474 ·Status: COMPLETED ·Phase: NA
-
The Effect of Faecal Microbiota Transplantation (FMT) on Eradication of Multidrug Resistant Organisms (MRO) in Intestinal Carriers
NCT05742074 ·Status: COMPLETED ·Phase: NA
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
Efficacy of a Probiotic or Fecal Microbiota Transplantation (FMT) on the Eradication of Rectal Multidrug-resistant Gram-negative Bacilli (MDR-GNB) Carriage (PROFTMDECOL)
NCT04431934 ·Status: UNKNOWN ·Phase: NA
-
High-fat Diet (HFD) and Small Intestinal Microbiome
NCT07019142 ·Status: COMPLETED ·Phase: NA
-
Networks of Bacterium-Metabolite Interactions in the Small Intestine
NCT04978077 ·Status: TERMINATED ·Phase: NA
-
FMT for Lung and Associated-organ Rescue Efficacy in MDRO-infected Ventilated Patients
NCT06970262 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea
NCT00304876 ·Status: COMPLETED
-
C Difficile Near-patient Diagnostics
NCT03857464 ·Status: COMPLETED ·Phase: NA
-
Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of Patients With COVID-19.
NCT05107245 ·Status: COMPLETED
-
Relationship Between C. Difficile Toxins' Serum Level With C. Difficile Infection
NCT03586206 ·Status: UNKNOWN
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)
NCT03298048 ·Status: TERMINATED ·Phase: PHASE2
-
FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach
NCT06071312 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
CMTS0929 for Clostridioides Difficile Infection
NCT06836427 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Role of the Gut Microbiome in Anti-tumor Therapy Induced Diarrhea
NCT05873231 ·Status: RECRUITING
-
PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA
NCT04259931 ·Status: UNKNOWN
-
Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease
NCT00350298 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma
NCT06107569 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms
NCT06524791 ·Status: NOT_YET_RECRUITING
-
Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection
NCT03462459 ·Status: COMPLETED ·Phase: PHASE2